 Zee News |
Lupin Settles Patent Dispute Over Glumetza Diabetes Treatment
Fox Business BY) Thursday said it has settled a patent infringement litigation with Santarus Inc. (SNTS) and DepoMed Inc. (DEPO) over the Glumetza extended-release tablets for diabetes treatment. The settlement allows Lupin to sell a generic version of Glumetza … Santarus and Depomed Announce Settlement with Lupin of GLUMETZA Patent LitigationMarketWatch (press release) all 24 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.